Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Using micro skin tissue columns improves skin wound healing and reduces scarring.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

New nano composite helps reduce scars and regrow hair during burn wound healing.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Minoxidil helps heart function but doesn't improve exercise ability and may cause complications.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

The Multi-Organ-Chip improves the growth and quality of skin and hair in the lab, potentially replacing animal testing.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The document concludes that a complete skin restoration biomaterial does not yet exist, and more clinical trials are needed to ensure these therapies are safe and effective.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Topical glucocorticoids thin the skin and change collagen structure.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

The new model detects hair clusters more accurately and efficiently, helping with early hair loss treatment and diagnosis.

The study concluded that the arachidonic acid pathway and the protein KRT79 play a role in determining the fineness of cashmere.